IL1B and graft versus host disease: In completed clinical trials, blockade of single cytokines alone, such as TNFα or interleukin-1 (IL-1), failed to improve clinical outcomes (24, 112) although there were evidence showing significant correlation between IL-1, IL-1β, and TNF-α and GVHD occurrence (113).